SC-113

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameSC-113
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 5 alpha reductase inhibitorsProstaglandin synthase inhibitors
TargetsSteroid 5 alpha reductase
Therapy Area/IndicationsErectile DysfunctionProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesScotia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScotia
Active IndicationsN/A
Inactive IndicationsErectile DysfunctionProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A